<DOC>
	<DOCNO>NCT02099695</DOCNO>
	<brief_summary>Treatment primary hyperhidrosis comparative study oxybutynin hydrochloride placebo . Hydrochloride may decrease symptom hyperhidrosis improve subject 's quality life .</brief_summary>
	<brief_title>Evaluate Efficacy Oxybutynin Chloride Patients With Primary Hyperhidrosis</brief_title>
	<detailed_description>Clinical Trial phase III , randomize , national , prospective , double-blind , multicenter , comparative oxybutynin hydrochloride placebo , hold participant age 18 year evaluate therapeutic efficacy safety oxybutynin chloride systemic treatment primary hyperhidrosis . Primary hyperhidrosis relatively common disorder , affect approximately 3 % population . It affect sex similarly age group , vary start age symptom accord affected part body : childhood - plantar palmar hyperhidrosis adolescence - axillary hyperhidrosis adult - craniofacial hyperhidrosis There family history associate 12.5 % 56.5 % participant , accord epidemiological study . Initially subject evaluated inclusion exclusion criterion screen safety test blood test , ECG tonometry , confirm enrollment . When include randomize correspond study arm start study treatment . During period study evaluate efficacy parameter drug . The treatment subject 8 week . The inclusion period foreseen 6 month may extend decrease accord pace inclusion . The data summarize accord study group ( per dose per visit , applicable ) appropriate descriptive statistic variable type . Frequency percentage use variable . The Adverse Events ( AE ) analyze base question investigator relation AE experienced subject . The orientation subject note symptom , date time event appear .</detailed_description>
	<mesh_term>Hyperhidrosis</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Understanding , agreement consent form sign ; Literate ; Confirmed diagnosis primary hyperhidrosis ; Screening test normal standard ; Absence pregnancy Betahuman chorionic gonadotropin test ; Secondary Hyperhidrosis ; Myasthenia gravis ; Lactation ; Hypersensitivity oxybutynin ; Use 500mg caffeine ; Alcoholism ; Use illicit drug ; Changes ECG ( echocardiogram ) tonometry ; Any clinical condition investigator considers clinically significant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Hyperhidrosis</keyword>
	<keyword>Oxybutynin</keyword>
</DOC>